JUL 19, 2019 11:21 AM PDT

Anti-cancer Drug Disguises as Fat

WRITTEN BY: Nouran Amin

According to a study published in the Journal of the American Chemical Society (JACS), a new drug-delivery system disguises as fat in order to outsmart tumors.

"It's like a Trojan horse," Northwestern University's Nathan Gianneschi, who led the research. "It looks like a nice little fatty acid, so the tumor's receptors see it and invite it in. Then the drug starts getting metabolized and kills the tumor cells."

Tumors seek the drug as a tasty fat that they can metabolize on—and so they invite them in. Once inside, the drug is activated and starts to immediately stop tumor growth. The engineered drug delivery system includes a long-chain fatty acid with bindings sites and then buried inside human serum albumin (HSA) that is know to carry fat molecules.

"It's like the fatty acid has a hand on both ends: one can grab onto the drug and one can grab onto proteins," Gianneschi said. "The idea is to disguise drugs as fats so that they get into cells and the body is happy to transport them around."

The unique anti-cancer drug is less toxic than current therapeutics and includes less side effects.

Northwestern University: A modified chemotherapy drug hitches a ride through the bloodstream on human serum albumin.

"Commonly used small-molecule drugs get into tumors -- and other cells," Gianneschi said. "They are toxic to tumors but also to humans. Hence, in general, these drugs have horrible side effects. Our goal is to increase the amount that gets into a tumor versus into other cells and tissues. That allows us to dose at much higher quantities without side effects, which kills the tumors faster."

Source: Northwestern University

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
AUG 22, 2019
Neuroscience
AUG 22, 2019
Using a popular anti-smoking drug to control brain cells
Researchers develop neuron receptors with the ability to interact with an FDA-approved anti-smoking drug. This technology has the potential to treat pain and seizures in humans....
AUG 22, 2019
Microbiology
AUG 22, 2019
Civil War Folk Remedies are Effective Against Drug-resistant Pathogens
Extracts from three plants were active against some of today's worst drug-resistant bacterial pathogens that infect wounds....
AUG 22, 2019
Microbiology
AUG 22, 2019
Vulnerability in Famously Hard-to-Target Viruses is Identified
The cold virus is famously difficult to target with drugs because it can mutate rapidly....
AUG 22, 2019
Health & Medicine
AUG 22, 2019
High Risk: Seizures and Coma Linked to Use of Synthetic Cannabinoids in Adolescents
A recent study by the American Academy of Pediatrics states that exposure to acute synthetic cannabinoid toxicity is far more dangerous to the adolesc...
AUG 22, 2019
Drug Discovery
AUG 22, 2019
HIV Therapeutics Places Risk of Neural Tube Defects
In a study published in the New England Journal of Medicine, women taking an HIV therapeutic drug containing dolutegravir have a higher risk of giving birt...
AUG 22, 2019
Drug Discovery
AUG 22, 2019
Medications Used for Atrial fibrillation May Increase Falls
Falls among older adults are a growing health concern that often lead to injury, hospitalization, and other severe complications. Older adults are even at...
Loading Comments...